SCHEMBL313991

SCHEMBL313991

C[C@@H](N)Cc1ccc(O)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
HTR1A P08908 1/20 0.48
HTR1D P28221 1/20 0.48
HTR1B P28222 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48
CYP1A2 P05177 1/20 0.48
NFKB1 P19838 1/20 0.48
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 2/20 0.47
ALOX5 P09917 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7312913 1.00 BLM (0.49) BLMNPSR1CYP2D6CYP2C9CYP2C19
SCHEMBL5796163 0.83 HSD17B10 (0.55) BLMNPSR1CYP2C9HTR1AHTR2A
SCHEMBL5796160 0.83 HSD17B10 (0.55) BLMNPSR1CYP2C9HTR1AHTR2A
SCHEMBL10706064 0.83 HTR2A (0.56) HTR1AHTR2AHTR2CHTR2BTAAR1
SCHEMBL5066588 0.81 AKR1C3 (0.44)
SCHEMBL4328756 0.80 CA12 (0.43) CYP2C9CA12CA1CA2CA7
SCHEMBL9254045 0.79 TDP1 (0.50) CYP2D6CYP2C9CYP2C19SLC6A2ALDH1A1
SCHEMBL1995440 0.78 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL11141533 0.77 FOLH1 (0.50) CYP2D6CYP2C9CYP2C19CA12CA1
SCHEMBL264745 0.77 FOLH1 (0.50) CYP2D6CYP2C9CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114159339-A Bud fiber for promoting regeneration and activity of skin collagen 广州市万千粉丝化妆品有限公司 2022-03-11 CN claimed
US-20200165192-A1 AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL LLC (US) 2020-05-28 US claimed
US-20180194717-A1 AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL LLC (US) 2018-07-12 US claimed
CN-104686208-A Usage and method for detection, processing and artificial cultivation of tussah cordyceps militaris taken as traditional Chinese medicinal materials BEIJING MAILLARD TRADITIONAL CHINESE MEDICINE DECOCTION PIECES TECHNOLOGY CO LTD 2015-06-10 CN claimed
US-20120094994-A1 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2012-04-19 US claimed
US-20110223254-A1 FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2011-09-15 US claimed
US-20090098180-A1 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2009-04-16 US claimed
CN-101243113-A Process for producing copolymer-1 HONG CHAN WAI (US) 2008-08-13 CN claimed
EP-1948713-A2 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM Bezwada Biomedical LLC (US) 2008-07-30 EP claimed
US-20070135355-A1 FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2007-06-14 US claimed
WO-2007047244-A2 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL LLC (US) 2007-04-26 WO claimed
US-20250295659-A1 METHODS FOR TREATING TRAUMATIC BRAIN INJURY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-09-25 US disclosed
CN-114015726-B Delivery, use and therapeutic application of CRISPR-CAS systems and compositions for targeting disorders and diseases with viral components 布罗德研究所有限公司 2025-06-24 CN disclosed
CN-113425857-B Delivery and use of CRISPR-CAS systems, vectors and compositions for liver targeting and treatment 布罗德研究所有限公司 2025-05-16 CN disclosed
CN-114591422-B Cystine knot support platform 豪夫迈·罗氏有限公司 2025-04-04 CN disclosed
US-4367225-A Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin THE MEDICAL COLLEGE OF OHIO (US) 1983-01-04 US disclosed
EP-0061356-A2 Antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin Medical College of Ohio (US) 1982-09-29 EP disclosed
US-4349544-A OXYTOCIN ANALOG CESKOSLOVENSKA AKADEMIE VED (CS) 1982-09-14 US disclosed
US-4237119-A OLIGOPEPTIDES CESKOSLOVENSKA AKADEMIE VED (CS) 1980-12-02 US disclosed
US-4118481-A LYSINE, ARGININE, TYROSINE, PROTEASE INHIBITION BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250295659-A1 METHODS FOR TREATING TRAUMATIC BRAIN INJURY CTTN, SRC, FYN BLM 2954/4885NPSR1 2793/4885CYP2D6 4871/4885
US-20070135355-A1 FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM DDT, DHCR7, NOTUM BLM 3113/4885NPSR1 271/4885CYP2D6 17/4885
US-20110223254-A1 FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM DDT, DHCR7, NOTUM BLM 3113/4885NPSR1 271/4885CYP2D6 17/4885
US-20090098180-A1 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM BCAT2, BCAT1, SLC7A1 BLM 4168/4885NPSR1 306/4885CYP2D6 781/4885
US-20180194717-A1 AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM SRRM2, SLC7A1, BCAT2 BLM 2483/4885NPSR1 342/4885CYP2D6 1597/4885
US-20200165192-A1 AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM SRRM2, SLC7A1, BCAT2 BLM 2483/4885NPSR1 342/4885CYP2D6 1597/4885
US-20120094994-A1 FUNCTIONALIZED AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM BCAT2, BCAT1, SLC7A1 BLM 4168/4885NPSR1 306/4885CYP2D6 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.